# Eidos Therapeutics, Inc. — Form D

Eidos Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-12. The offering totals $74.0M, of which $26.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-04-12
- Form: D
- Accession: 0001731831-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $74.0M
- Amount sold: $26.0M
- Remaining: $48.0M
- Investors: 13
- Date of first sale: 2018-03-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-309956

## Issuer

- Name: Eidos Therapeutics, Inc.
- CIK: 0001731831
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 101 MONTGOMERY STREET, SUITE 2550, SAN FRANCISCO, CA, 94104
- Phone: 415-887-1471

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Eric Aguiar | Director | Cambridge, MA |
| Hoyoung Huh | Director | TAMPA, FL |
| Neil Kumar | Director | PALO ALTO, CA |
| Rajeev Shah | Director | Boston, MA |
| Jonathan Fox | Executive Officer | Minneapolis, MN |
| Neil Kumar | Executive Officer | PALO ALTO, CA |
| UMA SINHA | Executive Officer | SAN FRANCISCO, CA |
| Christine Siu | Executive Officer | Del Mar, CA |

## More

- [CIK 1731831 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1731831&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001731831-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.